Nanomedicine Drug Delivery Market to Reach USD $219.3 Billion by 2029 at 15.5% CAGR
The Business Research Company
The Business Research Company's Nanomedicine Drug Delivery Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, November 17, 2025 /EINPresswire.com/ -- "Get 20% Off All Global Market Reports With Code ONLINE20 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors
How Big Is The Nanomedicine Drug Delivery Market In 2025?
The market size of nanomedicine drug delivery has experienced a swift expansion in the past few years. It is set to increase from $106.51 billion in 2024 to $123.37 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.8%. The historical growth is attributed to factors such as the rising prevalence of chronic illnesses, surging demand for targeted therapeutic options, increased global health care spending, significant investment in pharmaceutical infrastructure, the broadening scope of nanomedicine in the field of oncology, and heightened awareness regarding personalized medicine.
Expectations are high for the nanomedicine drug delivery market size to experience significant growth over the coming years, potentially expanding to $219.30 billion in 2029, with a compound annual growth rate (CAGR) of 15.5%. The surge anticipated during this forecast period could be influenced by factors such as the escalating number of aging population globally, incidences of cardiac and neurological diseases, increased concentration on precision medicine initiatives, the rising tide of government funds allocated for nanomedicine investigations, improvement of health infrastructure in burgeoning economies, and intensifying partnerships between pharmaceutical organisations and research institutions. The forecast period will likely also see trending innovations such as advancements in technology for drug carriers at a nanoparticle level, enhanced stimuli-responsive nanocarrier techniques, the invention of multifunctional nanomedicine modules, progression in nanoscale drug delivery to penetrate biological barriers, intensified research and development in customized nanotherapeutics, and improvements in hybrid nanocarrier systems for regulated release.
Download a free sample of the nanomedicine drug delivery market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29132&type=smp
What Are The Key Driving Factors For The Growth Of The Nanomedicine Drug Delivery Market?
The expansion of the nanomedicine drug delivery market is anticipated to be fueled by the increasing acceptance of personalized medicine. This is a medical strategy that tailors prevention and treatment methods to each patient's unique attributes such as their genetic makeup or disease subtype. The popularity of personalized medicine is rising, aided by genomic and molecular developments that permit treatments to be customized according to a person's genetic characteristics. This enhances effectiveness and allows for precise, focused care. Nanomedicine drug delivery augments personalized medicine by accurately targeting drugs to specific cells and adjusting doses and formulations for each individual, thereby improving the efficacy of treatment and minimizing adverse effects. For instance, as per the Personalized Medicine Coalition, a US-based global non-profit organization, in February 2024, the US Food and Drug Administration (FDA) sanctioned 16 new personalized treatments for patients with rare ailments in 2023, a substantial rise from six approvals in 2022. As a result, the escalating implementation of personalized medicine is propelling the growth of the nanomedicine drug delivery market.
Who Are The Key Players In The Nanomedicine Drug Delivery Industry?
Major players in the Nanomedicine Drug Delivery Global Market Report 2025 include:
• Pfizer Inc.
• Bristol-Myers Squibb Company
• Novartis AG
• Gilead Sciences Inc.
• Evonik Industries AG
• Ipsen Pharma S.A.S.
• Pacira BioSciences Inc.
• Camurus AB
• Arcturus Therapeutics Holdings Inc.
• Nanobiotix S.A.
What Are Some Emerging Trends In The Nanomedicine Drug Delivery Market?
The nanomedicine drug delivery market's major players are concentrating on creating solutions for drug delivery, such as artificial intelligence (AI)-propelled nano-delivery systems, to boost precision in targeting and expedite the creation of customized treatments. These advanced AI-enhanced nano-delivery platforms use AI to devise and finetune nanoparticles for exact drug targeting, which augments therapeutic results, minimizes adverse effects, and assists personalized treatment. One key example is METiS TechBio, a biotech firm from China that launched NanoForge, an AI-guided nano-delivery platform, in September 2025. This platform aims to transform how medicines are developed and delivered by merging AI with nanotechnology to improve lipid nanoparticle formations and facilitate exact drug delivery to target tissues, consequently making drug development quicker, safer, and more cost-effective. This technology aims to overcome vital hindrances in drug delivery linked with complex molecules like mRNA, thereby moving the field towards adjustable and programmable therapeutics.
What Segments Are Covered In The Nanomedicine Drug Delivery Market Report?
The nanomedicine drug deliverymarket covered in this report is segmented –
1) By Product Type: Nanoparticles, Liposomes, Micelles, Dendrimers, Nanotubes, Other Product Types
2) By Route Of Administration: Oral, Injectable, Topical, Other Routes Of Administration
3) By Application: Oncology, Cardiovascular Diseases, Neurology, Infectious Diseases, Other Applications
4) By End-User: Hospitals, Clinics, Research Institutes, Other End-Users
Subsegments:
1) By Nanoparticles: Polymeric Nanoparticles, Metallic Nanoparticles, Lipid-Based Nanoparticles, Magnetic Nanoparticles, Quantum Dots
2) By Liposomes: Conventional Liposomes, Stealth Liposomes, Cationic Liposomes, Anionic Liposomes, pH-Sensitive Liposomes
3) By Micelles: Polymeric Micelles, Lipid Micelles, Amphiphilic Block Copolymer Micelles, Stimuli-Responsive Micelles, Mixed Micelles
4) By Dendrimers: Polyamidoamine Dendrimers, Polypropylene Imine Dendrimers, Peptide Dendrimers, Carbohydrate Dendrimers, Hydroxyl-Terminated Dendrimers
5) By Nanotubes: Carbon Nanotubes, Peptide Nanotubes, Inorganic Nanotubes, Multi-Walled Nanotubes, Single-Walled Nanotubes
6) By Other Product Types: Nanospheres, Nanocapsules, Nanoemulsions, Nanogels, Hybrid Nanocarrier
View the full nanomedicine drug delivery market report:
https://www.thebusinessresearchcompany.com/report/nanomedicine-drug-delivery-global-market-report
Which Region Is Expected To Lead The Nanomedicine Drug Delivery Market By 2025?
In the Nanomedicine Drug Delivery Global Market Report 2025, North America held a leading spot in 2024. The region anticipating the most rapid growth in the upcoming period is expected to be Asia-Pacific. The report comprehensively covers several regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Browse Through More Reports Similar to the Global Nanomedicine Drug Delivery Market 2025, By The Business Research Company
Nanomedicine Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report
Pharmaceutical Drug Delivery Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report
Drug Delivery Devices Global Market Report Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
